Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine‐1‐phosphate receptor modulator

AIMS: Fingolimod is a sphingosine‐1‐phosphate (S1P) receptor modulator approved for the treatment of the relapsing form of multiple sclerosis (MS). It prevents the egress of lymphocyte subpopulations from lymphoid tissues into the circulation. Here, we explored the broad effects of fingolimod on gen...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:CNS Neurosci Ther
Main Authors: Angerer, Ines C., Hecker, Michael, Koczan, Dirk, Roch, Luisa, Friess, Jörg, Rüge, Annelen, Fitzner, Brit, Boxberger, Nina, Schröder, Ina, Flechtner, Kristin, Thiesen, Hans‐Jürgen, Winkelmann, Alexander, Meister, Stefanie, Zettl, Uwe K.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490155/
https://ncbi.nlm.nih.gov/pubmed/29314605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12793
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares